FGF21 and Obesity: To explore the potential of utilizing in vivo FGF21 gene therapy for the treatment of obesity, we subjected C57BL6/J mice to a very-high-fat diet for 10 weeks and then transfected the mice with either pLIVE-Empty control vector or pLIVE-FGF21-HA.